Showing results (891-900 of 1,019) with videos related to

Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|September 2, 2017
A cost-effectiveness analysis of first-line induction and maintenance treatment sequences in patients with advanced nonsquamous non-small-cell lung cancer in FranceKaisa Taipale, Katherine B Winfree, Mark Boye, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 15, 2015
Acceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness thresholdElizabeth A Griffiths, Janek K Hendrich, Samuel Dr Stoddart, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 23, 2015
AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysisSeye Abogunrin, Sarah Brand, Kamal Desai, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 26, 2015
Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostatsDerek Martyn, Lisa M Meckley, Gavin Miyasato, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 5, 2015
Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugsEnrica Menditto, Valentina Orlando, Silvia Coretti, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 10, 2015
Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow's milk allergy in SpainJulian F Guest, Diana Weidlich, J Ignacio Mascuñan Díaz, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 10, 2015
Estimating health-state utility values for patients with recurrent ovarian cancer using Functional Assessment of Cancer Therapy - General mapping algorithmsRobert Hettle, John Borrill, Gaurav Suri, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 19, 2017
Parenteral nutrition including an omega-3 fatty-acid-containing lipid emulsion for intensive care patients in China: a pharmacoeconomic analysisYufei Feng, Chao Li, Tian Zhang, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 20, 2017
"De-escalation" strategy using micafungin for the treatment of systemic Candida infections: budget impact in France and GermanyAnke van Engen, Montserrat Casamayor, Soyoung Kim, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 15, 2018
Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany - a real-world evidence analysisJürgen Stein, Jennifer Scarlet Haas, Siew Hwa Ong, et al.
Pageof 102